Accounting Estimates Based on Assumptions About the Containment of COVID-19
First written in FY2022-Q1. 6 of 11 entries say "Restated". Latest entry: FY2024.
The whole theme swung hardest in 2026: 5 of 22 companies on the "Worse" side.
- FY2024DroppedAnnual report
「Japan's economy during the current consolidated fiscal year was on a gradual recovery trend, as social and economic activity normalized following the reclassification of COVID-19 as a Category 5 infectious disease.」
The accounting estimates previously based on the timing of COVID-19 subsiding and the imposition of further large-scale restrictions are not included among the material accounting estimates in this filing. - FY2024-Q2RestatedAnnual report
「COVID-19 was reclassified as a Category 5 infectious disease effective 8 May 2023. After evaluating the impact of the above change, the company has made accounting estimates, including inventory valuation and impairment accounting for fixed assets, based on the assumption that COVID-19 will not result in further large-scale social restrictions, such as expanded closures and reduced operating hours at the commercial facilities where the company operates stores.」
The company continues to make accounting estimates, including inventory valuation and impairment, based on the assumption that no further large-scale social restrictions will be imposed following the reclassification as a Category 5 infectious disease. - FY2024-Q1RestatedAnnual report
「After evaluating the impact of the above change, the company has made accounting estimates, including inventory valuation and impairment accounting for fixed assets, based on the assumption that COVID-19 will not result in further large-scale social restrictions, such as expanded closures and reduced operating hours at the commercial facilities where the company operates stores.」
The company continues to make accounting estimates based on the assumption that no further large-scale social restrictions will be imposed even after COVID-19 was reclassified as a Category 5 infectious disease. - FY2023Assumption of a gradual recovery in economic activityAnnual report
「Based on the assumption that economic activity will gradually recover from the following consolidated fiscal year onward as restrictions on infection control measures are eased, accounting estimates for the current fiscal year, including inventory valuation and impairment accounting for fixed assets, have been made.」
The accounting estimates have been reorganized from the previous wording specifying when COVID-19 would subside to estimates based on the easing of restrictions and a gradual recovery in economic activity from the following consolidated fiscal year onward. - FY2023-Q3RestatedAnnual report
「There has been no material change from the information provided in the additional information section of the annual securities report for the previous fiscal year regarding the assumptions used in accounting estimates concerning the impact of COVID-19 during the first nine months of the current consolidated fiscal year.」
The company has reconfirmed that there has been no material change from the previous fiscal year in the basis for the accounting estimates concerning the impact of COVID-19. - FY2023-Q2RestatedAnnual report
「There has been no material change from the information provided in the additional information section of the annual securities report for the previous fiscal year regarding the assumptions used in accounting estimates concerning the impact of COVID-19 during the first six months of the current consolidated fiscal year.」
The company has reconfirmed that there has been no material change from the previous fiscal year in the basis for the accounting estimates concerning the impact of COVID-19. - FY2023-Q1RestatedAnnual report
「There has been no material change from the information provided in the additional information section of the annual securities report for the previous fiscal year regarding the assumptions used in accounting estimates concerning the impact of COVID-19 during the first quarter of the current consolidated fiscal year.」
The company states that there has been no material change from the previous fiscal year in the accounting estimates based on the assumption that COVID-19 will subside, among other factors. - FY2022SoftenedAnnual report
「Based on the assumption that no further large-scale social restrictions will be imposed, accounting estimates for the current fiscal year, including inventory valuation and impairment accounting for fixed assets, have been made.」
The basis for the accounting estimates has been changed from specifying the timing of convergence to assuming that no further large-scale restrictions will be imposed. - FY2022-Q3SoftenedAnnual report
「The Company expects consumer trends to remain uncertain, reflecting the spread of new COVID-19 variants and price increases driven by higher resource costs. After comprehensively considering the current situation and other factors, however, it is preparing accounting estimates for inventory valuation, impairment and other matters on the assumption that conditions will return to normal levels from the following consolidated fiscal year onward.」
The wording has changed from the previous assumption that the situation would gradually converge by the end of the fiscal year ending February 2022 and return to normal levels from the following fiscal year onward, to the wording that it would return to normal levels from the following fiscal year onward, with the timing of convergence no longer specified. - FY2022-Q2RestatedAnnual report
「The Company prepared accounting estimates for inventory valuation, impairment and other matters on the assumption that COVID-19 would gradually subside and move toward recovery by the end of the fiscal year ending February 2022, and return to normal levels from the following consolidated fiscal year onward.」
The Company reconfirmed the accounting assumption that COVID-19 would gradually subside by the end of the fiscal year ending February 2022 and return to normal levels thereafter. - FY2022-Q1First statedAnnual report
「Against this backdrop, after comprehensively considering the current situation and other factors, the Company prepared accounting estimates for inventory valuation, impairment and other matters on the assumption that COVID-19 would gradually subside and move toward recovery by the end of the fiscal year ending February 2022, and return to normal levels from the following consolidated fiscal year onward.」
The Company prepared accounting estimates for inventory valuation, impairment and other matters on the assumption that COVID-19 would subside by the end of the fiscal year ending February 2022 and return to normal levels thereafter.